Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy CASI Pharmaceuticals stock

Learn how to easily invest in CASI Pharmaceuticals stock.

CASI Pharmaceuticals Inc is a biotechnology business based in the US. CASI Pharmaceuticals shares (CASI) are listed on the NASDAQ and all prices are listed in US Dollars. CASI Pharmaceuticals employs 176 staff and has a trailing 12-month revenue of around $34.9 million.

How to buy shares in CASI Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CASI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

CASI Pharmaceuticals stock price (NASDAQ: CASI)

Use our graph to track the performance of CASI stocks over time.

CASI Pharmaceuticals shares at a glance

Information last updated 2022-09-25.
Latest market close$2.68
52-week range$2.24 - $12.70
50-day moving average $3.35
200-day moving average $5.45
Wall St. target price$22.67
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.26

Buy CASI Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CASI Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CASI Pharmaceuticals price performance over time

Historical closes compared with the close of $2.68 from 2022-09-29

1 week (2022-09-23) 2.29%
1 month (2022-09-01) -29.10%
3 months (2022-07-01) -7.27%
6 months (2022-03-31) 230.99%
1 year (2021-09-30) 125.21%
2 years (2020-10-01) 71.79%
3 years (2019-10-01) 3.29
5 years (2017-09-29) 51.41%

CASI Pharmaceuticals financials

Revenue TTM $34.9 million
Gross profit TTM $17.6 million
Return on assets TTM -15.8%
Return on equity TTM -30.23%
Profit margin -91.97%
Book value $4.92
Market capitalisation $35.6 million

TTM: trailing 12 months

CASI Pharmaceuticals share dividends

We're not expecting CASI Pharmaceuticals to pay a dividend over the next 12 months.

Have CASI Pharmaceuticals's shares ever split?

CASI Pharmaceuticals's shares were split on a 1:10 basis on 1 June 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CASI Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for CASI Pharmaceuticals shares which in turn could have impacted CASI Pharmaceuticals's share price.

CASI Pharmaceuticals share price volatility

Over the last 12 months, CASI Pharmaceuticals's shares have ranged in value from as little as $2.24 up to $12.7. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CASI Pharmaceuticals's is 0.4435. This would suggest that CASI Pharmaceuticals's shares are less volatile than average (for this exchange).

CASI Pharmaceuticals overview

CASI Pharmaceuticals, Inc. , a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co.

Frequently asked questions

What percentage of CASI Pharmaceuticals is owned by insiders or institutions?
Currently 32.693% of CASI Pharmaceuticals shares are held by insiders and 16.294% by institutions.
How many people work for CASI Pharmaceuticals?
Latest data suggests 176 work at CASI Pharmaceuticals.
When does the fiscal year end for CASI Pharmaceuticals?
CASI Pharmaceuticals's fiscal year ends in December.
Where is CASI Pharmaceuticals based?
CASI Pharmaceuticals's address is: 9620 Medical Center Drive, Rockville, MD, United States, 20850
What is CASI Pharmaceuticals's ISIN number?
CASI Pharmaceuticals's international securities identification number is: US14757U2087
What is CASI Pharmaceuticals's CUSIP number?
CASI Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 14757U109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site